Iperion (NZSE:IPR) Common Stock: NZ$5.67 Mil (As of Sep. 2025)


What is Iperion Common Stock?

Iperion NZSE:IPR Common Stock is NZ$5.67 Mil as of Sep. 2025. The stock has 2 warning signs investors should review.

Iperion's quarterly common stock stayed the same from Sep. 2024 (NZ$5.67 Mil) to Mar. 2025 (NZ$5.67 Mil) and stayed the same from Mar. 2025 (NZ$5.67 Mil) to Sep. 2025 (NZ$5.67 Mil).

Iperion's annual common stock stayed the same from Mar. 2023 (NZ$5.67 Mil) to Mar. 2024 (NZ$5.67 Mil) and stayed the same from Mar. 2024 (NZ$5.67 Mil) to Mar. 2025 (NZ$5.67 Mil).

Iperion Common Stock Historical Data

* Premium members only.

The historical data trend for Iperion's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Iperion Common Stock Chart

Iperion Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.67 5.67 5.67 5.67 5.67

Iperion Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.67 5.67 5.67 5.67 5.67

Iperion Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NZ$5.67 Mil mean?
Iperion (NZSE:IPR) has a Common Stock of NZ$5.67 Mil as of Sep. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Iperion and its competitors.
Is Iperion's Common Stock too high?
Iperion's current Common Stock is NZ$5.67 Mil.
How does Iperion's Common Stock compare to CCCX and CEPF?
Iperion's Common Stock of NZ$5.67 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Diversified Financial Services company?
A good Common Stock depends on the Diversified Financial Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Iperion and its competitors. Iperion's current Common Stock is NZ$5.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iperion stock overvalued right now?
Iperion (NZSE:IPR) has a current Common Stock of NZ$5.67 Mil. The current Common Stock is NZ$5.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Iperion (NZSE:IPR), the current Common Stock is NZ$5.67 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Iperion Business Description

Address c/o Duncan Cotterill, 50 Customhouse Quay, Level 5 Tower Building, Wellington, NTL, NZL, 6011
Iperion Ltd is engaged in the process of commercializing a novel antimicrobial coating product, being marketed under the name Pathoglaze. The company is engaged in manufacturing, selling, distributing, importing, and exporting a self-cleaning, transparent, antimicrobial surface coating product.